insitro, a Casdin/ARCH/GV investment, is a data-driven drug discovery and development company using machine learning and computation at scale to transform the way that drugs are discovered and developed for patients.
In 2022, Occam placed Theo Karaletsos, PhD as VP, Data Science/Machine Learning at insitro. Karaletsos joined insitro from Facebook, where he was a staff research scientist in the Probability Organization, working on probabilistic treatments and robustness of neural networks and probabilistic programming. Previously, he was a founding member and senior researcher at Uber AI Labs in San Francisco, where he worked on machine intelligence. In his earlier roles, Theo was a researcher at artificial intelligence startup Geometric Intelligence, which was acquired by Uber to form Uber AI Labs, and was a researcher at the Memorial Sloan Kettering Cancer Center. Theo did his Ph.D. work in machine learning and bioinformatics at the Max Planck Institute for Intelligent Systems.
